A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer

Ignace Vergote, Russell J. Schilder, Charles H. Pippitt, Shirley Wong, Alan N. Gordon, Sidney A Scudder, Frederic Kridelka, Luc Dirix, Joseph W. Leach, Sumitra Ananda, Nuwan Nanayakkara, Rebeca Melara, Michael B. Bass, Jason Litten, Henry Adewoye, Robert M. Wenham

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences